학술논문

Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JAN 20 2015, 33 3, 1p. Supplement: S
Subject
Language
English
ISSN
15277755